Ole Wiborg has more than 25 years of executive experience in the pharma and biotech industry and is the co-founder of five companies in the life science/MedTech field. In 2016, he co-founded and led the MedTech company Cura Nordic until a successful exit in 2018 by way of an asset deal to Karo Pharma AB in Sweden. In 2019, he co-founded Zerion Pharma and has since been the CEO of Zerion Pharma. Ole holds an M.Sc. in Chemical Engineering from the Technical University (DK) and a B.Econ.